These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3046484)

  • 41. Randomized, double-blind, multicenter comparison of oral cefditoren 200 or 400 mg BID with either cefuroxime 250 mg BID or cefadroxil 500 mg BID for the treatment of uncomplicated skin and skin-structure infections.
    Bucko AD; Hunt BJ; Kidd SL; Hom R
    Clin Ther; 2002 Jul; 24(7):1134-47. PubMed ID: 12182257
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Teicoplanin in the treatment of skin and soft tissue infections.
    Turpin PJ; Taylor GP; Logan MN; Wood MJ
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():117-22. PubMed ID: 2965123
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative, double-blind study of oral ciprofloxacin and intravenous cefotaxime in skin and skin structure infections.
    Ramirez-Ronda CH; Saavedra S; Rivera-Vázquez CR
    Am J Med; 1987 Apr; 82(4A):220-3. PubMed ID: 3555040
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intravenous cefazolin plus oral probenecid versus oral cephalexin for the treatment of skin and soft tissue infections: a double-blind, non-inferiority, randomised controlled trial.
    Dalen D; Fry A; Campbell SG; Eppler J; Zed PJ
    Emerg Med J; 2018 Aug; 35(8):492-498. PubMed ID: 29914924
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cephalosporins in cutaneous infections. A prospective comparison of two dosage regimens of ceftazidime for therapy of skin and skin structure infections.
    Parish LC; Witkowski JA; Snow R; Eron L; Mogabgab WJ
    Int J Dermatol; 1986 May; 25(4):258-65. PubMed ID: 3519482
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravenous fleroxacin versus ceftazidime for lower respiratory tract and skin and soft-tissue infections.
    Huston MJ; Lentino JR
    Clin Ther; 1992; 14(4):595-602. PubMed ID: 1525793
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Fundamental and clinical studies of sustained release cephalexin (L-Keflex) in the field of oral surgery (author's transl)].
    Morihana T; Ueda K; Muraoka M; Tsushima T; Kodama M; Nagata K; Nakao K; Shimada K
    Jpn J Antibiot; 1980 Apr; 33(4):514-21. PubMed ID: 6997536
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A multicenter comparative study of cefotetan once daily and cefoxitin thrice daily for the treatment of infections of the skin and superficial soft tissue.
    Geckler RW; Eng RH; Fabian TC; Echols RM; Jemsek JG; LeFrock JL; Mogabgab WC; Wilson SE
    Am J Surg; 1988 May; 155(5A):91-5. PubMed ID: 3287976
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Systemic antimicrobial therapy in skin and skin structure infections: comparison of temafloxacin and ciprofloxacin.
    Parish LC; Jungkind DL
    Am J Med; 1991 Dec; 91(6A):115S-119S. PubMed ID: 1662880
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison between cephalexin two- and four-time per day regimens in group A streptococcal pharyngitis.
    Stillerman M; Aronovitz GH; Durnell MD; Rosenberg R
    Clin Pediatr (Phila); 1984 Jun; 23(6):348-51. PubMed ID: 6373094
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative double-blinded study between mupirocin and tetracycline ointments for treating skin infections.
    Wong KS; Lim KB; Tham SN; Ling ML; Tan T
    Singapore Med J; 1989 Aug; 30(4):380-3. PubMed ID: 2510312
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparison of the efficacy and safety of mupirocin cream and cephalexin in the treatment of secondarily infected eczema.
    Rist T; Parish LC; Capin LR; Sulica V; Bushnell WD; Cupo MA
    Clin Exp Dermatol; 2002 Jan; 27(1):14-20. PubMed ID: 11952661
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cephalexin: a review of its antibacterial, pharmacological and therapeutic properties.
    Speight TM; Brogden RN; Avery GS
    Drugs; 1972; 3(1):9-78. PubMed ID: 4559812
    [No Abstract]   [Full Text] [Related]  

  • 54. Cephalexin therapy for infections in the elderly and other vulnerable patients.
    Cooke DM; Browning AK
    Curr Med Res Opin; 1980; 7(1):62-7. PubMed ID: 7428416
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Comparative studies of the efficacy, safety and usefulness of S6472, cefaclor and cephalexin on complicated urinary tract infection by the double-blind method].
    Kamidono S; Arakawa S; Fujii A; Kataoka N; Umezu K; Ishigami J; Hirooka K; Shimatani N; Matsushita M; Hikosaka K
    Jpn J Antibiot; 1985 Oct; 38(10):2735-69. PubMed ID: 3908727
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impetigo. Current etiology and comparison of penicillin, erythromycin, and cephalexin therapies.
    Demidovich CW; Wittler RR; Ruff ME; Bass JW; Browning WC
    Am J Dis Child; 1990 Dec; 144(12):1313-5. PubMed ID: 2244610
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ticarcillin plus clavulanic acid versus moxalactam therapy of osteomyelitis, septic arthritis, and skin and soft tissue infections.
    Siebert WT; Kopp PE
    Am J Med; 1985 Nov; 79(5B):141-5. PubMed ID: 4073082
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cephalexin compared to ampicillin treatment of otitis media.
    Stechenberg BW; Anderson D; Chang MJ; Dunkle L; Wong M; Van Reken D; Pickering LK; Feigin RD
    Pediatrics; 1976 Oct; 58(4):532-6. PubMed ID: 787913
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cephalexin in the treatment of acute and chronic maxillary sinusitis.
    Schaefer SD; Ronis ML
    South Med J; 1985 Jan; 78(1):45-7. PubMed ID: 3871254
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cefuroxime axetil in the treatment of cutaneous infections.
    Parish LC; Cocchetto DM; Werner K; Jungkind DL; Witkowski J
    Int J Dermatol; 1987; 26(6):389-93. PubMed ID: 3305394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.